Literature DB >> 2337505

Interleukin-1 production by immunologically hyporeactive tumour-bearing mice.

V Holán1, M Lipoldová.   

Abstract

Mice bearing progressively growing syngeneic methylcholanthrene-induced sarcomas are immunologically hyporeactive. However, both basal (steady-state) and bacterial lipopolysaccharide (LPS)-induced synthesis of mRNA for interleukin-1 (IL-1) in peritoneal exudate cells (PEC) or spleen cells were comparable in control and tumour-bearing animals. Furthermore, the production of IL-1 by PEC stimulated with LPS in the presence of indomethacin was same in control and tumour-bearing mice. The results thus demonstrate that LPS-stimulated cells from animals bearing progressively growing syngeneic sarcomas synthesise the same quantities of mRNA for IL-1 and produce comparable amounts of IL-1 as do cells from normal animals, in spite of the profound immunological hyporeactivity of the former.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337505      PMCID: PMC1971620          DOI: 10.1038/bjc.1990.151

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

Review 1.  Interleukin 1: an immunological perspective.

Authors:  S K Durum; J A Schmidt; J J Oppenheim
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests.

Authors:  J Bubeník; M Indrová; S Nemecková; M Malkovský; B Von Broen; V Pálek; J Anderlíková
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

3.  Analysis of T-cell receptor usage in activated T-cell clones from Hashimoto's thyroiditis and Graves' disease.

Authors:  M Lipoldova; M Londei; B Grubeck-Loebenstein; M Feldmann; M J Owen
Journal:  J Autoimmun       Date:  1989-02       Impact factor: 7.094

Review 4.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

5.  Establishment and characterization of a permanent T-cell line producing an antigen non-specific suppressor factor.

Authors:  V Holán; M Lipoldová; M Takác; J Cerná; A Vancatová; D Cechová; L Veselský; M Hasek
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

6.  Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production.

Authors:  J Herman; M C Kew; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Endotoxin-induced in vitro release of interleukin-1 by cancer patients' monocytes: relation to stage of disease.

Authors:  S Pollack; A Micali; D W Kinne; W E Enker; N Geller; H F Oettgen; M K Hoffmann
Journal:  Int J Cancer       Date:  1983-12-15       Impact factor: 7.396

8.  Monocyte and lymphocyte interaction in patients with advanced cancer. Evidence for deficient IL-1 production.

Authors:  L B Santos; F T Yamada; M A Scheinberg
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

9.  Preparation of goat antibodies against interleukin 1: use of an immunoadsorbent to purify interleukin 1.

Authors:  S B Mizel; M Dukovich; J Rothstein
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

10.  Cloning and expression of murine interleukin-1 cDNA in Escherichia coli.

Authors:  P T Lomedico; U Gubler; C P Hellmann; M Dukovich; J G Giri; Y C Pan; K Collier; R Semionow; A O Chua; S B Mizel
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

View more
  1 in total

1.  Inhibitory versus stimulatory effects of natural human interferon-alpha on proliferation of lymphocyte subpopulations.

Authors:  V Holán; S Nakamura; J Minowada
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.